Document:

Exhibit 10.6

 

EXECUTION VERSION

 

SPONSOR SUPPORT AGREEMENT

 

This Sponsor Support
Agreement (this “Sponsor Agreement”) is dated as of November 23, 2020, by and among Apex Technology Sponsor
LLC, a Delaware limited liability company (the “Apex Sponsor” and together with any “Insider Sponsor”
who becomes a party to this Sponsor Agreement pursuant to Section 1.14, the “Sponsors” and each, a “Sponsor”),
Apex Technology Acquisition Corp., a Delaware corporation (“Apex”), and AvePoint, Inc., a Delaware corporation
(the “Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to
such terms in the Business Combination Agreement.

 

RECITALS

 

WHEREAS, as of the date
hereof, each Sponsor is the holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the
Exchange Act) of certain shares of Apex Class A Common Stock (“Apex Common Shares”), Apex Class B Common Stock
(the “Founder Shares” and collectively with the Apex Common Shares, the “Apex Shares”) and
warrants exercisable for shares of Apex Common Stock (the “Placement Warrants”) in each case as set forth on
Schedule I attached hereto (all such securities or other equity securities, together with any shares of the Apex’s
capital stock or other equity securities of which ownership of record or the power to vote (including, without limitation, by proxy
or power of attorney) is hereafter acquired by any such Sponsor during the period from the date hereof through the Expiration Time
are referred to herein as the “Subject Securities”);

 

WHEREAS, contemporaneously
with the execution and delivery of this Sponsor Agreement, Apex, Athena Technology Merger Sub, Inc., a Delaware corporation (“First
Merger Sub”), Athena Technology Merger Sub 2, LLC, a Delaware limited liability company (“Second Merger Sub”
and, together with First Merger Sub, “Merger Subs” and each, a “Merger Sub”), and the Company,
have entered into a Business Combination Agreement and Plan of Reorganization (as amended or modified from time to time, the “Business
Combination Agreement”), dated as of the date hereof, pursuant to which, among other transactions, First Merger Sub will
be merged with and into the Company (the “First Merger”), with the Company continuing on as the surviving entity
(the “Surviving Corporation”) in the First Merger and, as soon as practicable following the First Merger and
as part of the same overall transaction of the First Merger, the Surviving Corporation will merge with and into Second Merger Sub
(the “Second Merger” and together with the First Merger, the “Mergers”), with Second Merger
Sub continuing on as the surviving entity in the Second Merger, on the terms and conditions set forth therein; and

 

WHEREAS, as an inducement
to Apex and the Company to enter into the Business Combination Agreement and to consummate the transactions contemplated therein,
the parties hereto desire to agree to certain matters as set forth herein.

 

AGREEMENT

 

NOW, THEREFORE, in consideration
of the foregoing and the mutual agreements contained herein, and intending to be legally bound hereby, the parties hereto hereby
agree as follows:

 

      

     

    

 

ARTICLE
I

SPONSOR SUPPORT AGREEMENT; COVENANTS

 

Section 1.1 Binding
Effect of Business Combination Agreement

 

. Each Sponsor hereby acknowledges that
it has read the Business Combination Agreement and this Sponsor Agreement and has had the opportunity to consult with its tax and
legal advisors. Each Sponsor shall be bound by and comply with Section 7.11 (Public Announcements) of the Business Combination
Agreement (and any relevant definitions contained in such Section) as if such Sponsor was an original signatory to the Business
Combination Agreement with respect to such provision and each reference to Apex in such provision referred to such Sponsor.

 

Section 1.2 Exclusivity.
During the period commencing on the date hereof and ending at the Expiration Time (as defined below), no Sponsor shall, nor shall
any Sponsor direct any of its Representatives to, solicit, initiate, continue, or engage in discussions or negotiations with, or
enter into any agreement with, or encourage, respond, provide any information to, or commence due diligence with respect to, any
person (other than the Company, its stockholders or any of their affiliates or Representatives), concerning an Apex Business Combination
Proposal. Each Sponsor shall, and shall cause its controlled affiliates to, and shall cause their respective Representatives to,
immediately cease any and all existing discussions or negotiations with any person with respect to any Apex Business Combination
Proposal (other than the Transactions) to the extent required by the Business Combination Agreement.

 

Section 1.3 No
Transfer. During the period commencing on the date hereof and ending on the earliest of (a) the Effective Time and (b) such
date and time as the Business Combination Agreement shall be terminated in accordance with Section 9.01 thereof (the earlier of
(a) and (b), the “Expiration Time”), no Sponsor shall (i) sell, offer to sell, contract or agree to sell, hypothecate,
pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, file (or participate
in the filing of) a registration statement with the SEC (other than the Registration Statement) or establish or increase a put
equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act,
with respect to any Subject Securities owned by such Sponsor, (ii) deposit any Subject Securities into a voting trust or enter
into a voting agreement or arrangement or grant any proxy or power of attorney with respect thereto that is inconsistent with
this Sponsor Agreement or otherwise transfer any voting or approval rights with respect to the Subject Securities, (iii) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of any Subject Securities owned by such Sponsor or (iv) publicly announce any intention to effect any transaction specified in
clause (i), (ii) or (iii).

 

Section 1.4 New
Shares. In the event that (a) any Subject Securities are issued to such Sponsor after the date of this Sponsor Agreement pursuant
to any stock dividend, stock split, recapitalization, reclassification, combination or exchange of Subject Securities of, on or
affecting the Subject Securities owned by such Sponsor or otherwise, (b) such Sponsor purchases or otherwise acquires beneficial
ownership of any Subject Securities after the date of this Sponsor Agreement, or (c) such Sponsor acquires the right to vote or
share in the voting of any Subject Securities after the date of this Sponsor Agreement (such shares of Apex Capital Stock or other
equity securities of Apex, collectively the “New Securities”), then such New Securities acquired or purchased
by such Sponsor shall be subject to the terms of this Sponsor Agreement to the same extent as if they constituted Subject Securities
owned by such Sponsor as of the date hereof.

 

     2

     

    

 

Section 1.5 Waiver
of Anti-Dilution Provision.

 

(a) Section
4.3(b)(i) of the Apex Amended and Restated Certificate of Incorporation, dated September 16, 2019 (the “Apex Charter”)
provides that each share of Class B Common Stock, par value $0.0001 per share, of Apex (“Apex Existing Class B Common
Stock”) shall automatically convert into one share of Apex Class A Common Stock (the “Initial Conversion Ratio”)
on the closing of the Business Combination (as defined in the Apex Charter) and Section 4.3(b)(ii) of the Apex Charter provides
that the Initial Conversion Ratio shall be adjusted (the “Adjustment”) in the event that additional shares of Apex
Class A Common Stock or Equity-linked Securities (as defined in the Charter) are issued or deemed issued in excess of the amounts
sold in Apex’s initial public offering of securities and related to the closing of the initial Business Combination such
that the holders of the Apex Existing Class B Common Stock shall continue to own 25% of the issued and outstanding shares of the
Apex Common Stock.

 

(b) As
of and conditioned upon the Closing, each Sponsor hereby irrevocably relinquishes and waives (for itself and for its successors,
heirs and assigns), to the fullest extent permitted by law, any and all rights such Sponsor has or will have under Section 4.3(b)(ii)
of the Apex Charter to receive shares of Apex Class A Common Stock in excess of the number issuable at the Initial Conversion Ratio
upon conversion of the Apex Existing Class B Common Stock held by such Sponsor in connection with the Transactions as a result
of any Adjustment and, as a result, the shares of Apex Existing Class B Common Stock shall convert into shares of Apex Class A
Common Stock (or such equivalent security) at the Closing on a one-for-one basis.

 

Section 1.6 Closing
Date Deliverables. On the Closing Date, each Sponsor that holds any Subject Securities shall deliver to Apex and the Company
(a) a duly executed copy of the Amended and Restated Registration Rights Agreement substantially in the form attached as Exhibit
A to the Business Combination Agreement and (b) a duly executed copy of the Lock-Up Agreement substantially in the form attached
as Exhibit B to the Business Combination Agreement.

 

Section 1.7 Sponsor Agreements.

 

(a) At
any meeting of the stockholders of Apex, however called, or at any adjournment thereof, or in any other circumstance in which the
vote, consent or other approval of the shareholders of Apex is sought, each Sponsor shall (i) appear at each such meeting or otherwise
cause all of its Apex Shares to be counted as present thereat for purposes of calculating a quorum and (ii) vote (or cause to be
voted), or execute and deliver a written consent (or cause a written consent to be executed and delivered) covering, all of its,
his, or her Apex Shares:

 

(i) in
favor of each Apex Proposal;

 

(ii) against
any Apex Business Combination Proposal or any proposal relating to an Apex Business Combination Proposal (in each case, other than
the Apex Proposals);

 

     3

     

    

 

(iii) against
any business combination agreement or merger (other than the Business Combination Agreement and the Mergers), consolidation, combination,
sale of substantial assets, reorganization, recapitalization, dissolution, liquidation or winding up of or by Apex;

 

(iv) against
any change in the business, management or Board of Directors of Apex (other than in connection with the Apex Proposals);

 

(v) against
any proposal, action or agreement that would (A) impede, frustrate, prevent or nullify any provision of this Sponsor Agreement,
the Business Combination Agreement or the Mergers, (B) result in a breach in any respect of any covenant, representation, warranty
or any other obligation or agreement of Apex or the Merger Subs under the Business Combination Agreement, (C) result in any of
the conditions set forth in Article VIII of the Business Combination Agreement not being fulfilled or (D) change in any manner
the dividend policy or capitalization of, including the voting rights of any class of capital stock of, Apex; and

 

(vi) to
take such other action reasonably requested by the Company in support of the Mergers, the Business Combination Agreement and any
of the Transactions.

 

Each Sponsor hereby
agrees that such Sponsor shall not commit or agree to take any action inconsistent with the foregoing.

 

(b) Each
Sponsor shall comply with, and fully perform all of its obligations, covenants and agreements set forth in, that certain Letter
Agreement, dated as of September 16, 2019, by and among the Sponsors, Apex and the other parties thereto (the “Voting
Letter Agreement”), including the obligations of such Sponsor pursuant to Section 1 therein to not redeem any Apex Shares
owned by such Sponsor in connection with the transactions contemplated by the Business Combination Agreement.

 

(c) During
the period commencing on the date hereof and ending on the earlier of the Effective Time and the termination of the Business Combination
Agreement pursuant to Section 9.01 thereof, without the prior written consent of the Company, no Sponsor shall modify or amend
any contract between or among such Sponsor or any affiliate of such Sponsor (other than Apex or any of its subsidiaries), on the
one hand, and Apex or any of Apex’s subsidiaries, on the other hand, including, for the avoidance of doubt, the Voting Letter
Agreement.

 

(d) Apex
and Apex Sponsor hereby agree that the provisions of Section 7 of the Voting Letter Agreement shall not be amended or waived prior
to the Effective Time without the prior written consent of the Company.

 

Section 1.8 Further
Assurances. Each Sponsor shall take, or cause to be taken, all actions and do, or cause to be done, all things reasonably
necessary under applicable Laws to consummate the Mergers and the other transactions contemplated by the Business Combination
Agreement on the terms and subject to the conditions set forth therein and herein.

 

     4

     

    

 

Section 1.9 No
Inconsistent Agreement. Each Sponsor hereby represents and covenants that such Sponsor has not entered into, and shall not
enter into, any agreement that would restrict, limit or interfere with the performance of such Sponsor’s obligations hereunder.
Prior to the Expiration Time, Sponsor shall not liquidate or dissolve.

 

Section 1.10 Ineligible
Apex IPO Underwriting Fees. On the Closing Date, the Apex Sponsor shall pay or satisfy (or cause to be paid or satisfied at
the sole cost and expense of Sponsor, and for the avoidance of doubt, without any contribution by Apex or any of its Subsidiaries)
any unpaid Ineligible Apex IPO Underwriting Fees in cash.

 

Section 1.11 Vesting
Provisions.

 

(a) No
Transfer of Sponsor Earn-Out Shares. The Apex Sponsor agrees that, on the Closing Date, 2,916,700 shares of Apex Common Stock
(the “Sponsor Earn-Out Shares”) held by the Apex Sponsor as of the Closing shall be subject to the vesting provisions
set forth in this Section 1.11. The Apex Sponsor agrees that it shall not (and will cause its affiliates and any Insider Sponsor
that holds any Sponsor Earn-Out Shares not to) transfer any Sponsor Earn-Out Shares held by the Apex Sponsor prior to the date
such Sponsor Earn-Out Shares become vested pursuant to this Section 1.11.

 

(b) Vesting
of Sponsor Earn-Out Shares. The Sponsor Earn-Out Shares shall be placed in an escrow account pursuant to an escrow agreement
reasonably acceptable to the Company on the Closing Date and shall be subject to vesting and be released to the Apex Sponsor as
follows:

 

(i) 
100% of the Sponsor-Earn Out Shares shall vest and be released to the Apex Sponsor if at any time prior to or as of the seventh
anniversary of the Closing, the Closing Price is greater than or equal to $15.00 (as adjusted for share splits, share capitalization,
reorganizations, recapitalizations and the like) over any 20 Trading Days within any 30 Trading Day period; and

 

(ii) 100%
of the remaining Sponsor-Earn Out Shares that have not previously vested under Section 1.11(b)(i) shall vest and be released to
the Apex Sponsor if at any time prior to or as of the seventh anniversary of the Closing, Apex consummates a Subsequent Transaction.

 

(c) Equitable
Adjustment. Notwithstanding the foregoing, the Closing Price targets in Section 1.11(b) shall be equitably adjusted to reflect
appropriately the effect of any stock split, reverse stock split, stock dividend (including any dividend or distribution of securities
convertible into shares of Apex Common Stock), reorganization, recapitalization, reclassification, combination, merger, sale or
exchange of shares or other like change with respect to shares of Apex Common Stock occurring on or after the date hereof and prior
to the time any such Sponsor Earn-Out Shares are delivered to the Apex Sponsor.

 

Section 1.12 Vesting
Shares Legend.

 

(a) Each Sponsor agrees that the Sponsor
Earn-Out Shares shall be subject to the restrictions set forth herein, including as set forth in Section 1.3.

 

     5

     

    

 

(b) Each Sponsor agrees
that, in connection with the Transactions, the Sponsor Earn-Out Shares shall, concurrently with the Closing, have the Legend (as
defined below) affixed to them as set forth in this Section 1.12. The restrictions set forth pursuant to this Sponsor Agreement
are referred to as the “Transfer Restrictions”. Each Sponsor acknowledges and agrees that the Sponsor Earn-Out
Shares shall be subject to the Transfer Restrictions until such Transfer Restrictions expire in accordance with the terms of this
Sponsor Agreement.

 

(c)  The
books and records of Apex evidencing the Sponsor Earn-Out Shares shall be stamped or otherwise imprinted with a legend (the “Legend”)
in substantially the following form:

 

THE SECURITIES EVIDENCED
HEREIN ARE SUBJECT TO RESTRICTIONS ON TRANSFER, AND CERTAIN OTHER AGREEMENTS, SET FORTH IN THE SPONSOR SUPPORT AGREEMENT DATED
AS OF NOVEMBER 23, 2020, BY AND AMONG APEX TECHNOLOGY SPONSOR LLC AND THE OTHER PARTIES THERETO.

 

Section 1.13 Tax Matters.
The parties to this Sponsor Agreement hereby acknowledge and agree that (A) for U.S. federal income tax purposes, (i) the Apex
Sponsor will be treated as the owner of the Sponsor Earn-Out Shares during the period such Sponsor Earn-Out Shares are subject
to vesting pursuant to Section 1.11(a) and (ii) the release to Sponsor from an escrow account of any Sponsor Earn-Out Shares shall
not be treated as resulting in any a transfer of property to Sponsor and (B) the parties shall file all tax returns consistent
with this Section 1.14 and, except to the extent otherwise required by a “determination” as such term is used in Section 1313
of the Code, take no position or action inconsistent with this Section 1.14 (whether in audits, tax returns or otherwise).

 

Section 1.14 Additional
Parties. In the event that after the date of this Sponsor Agreement, any Insider Sponsor acquires beneficial ownership of any
Subject Securities, then the Apex Sponsor shall cause such Insider Sponsor to become a party to this Sponsor Agreement by executing
a counterpart signature page hereto as a Sponsor, and such person shall thereby be bound by, and subject to, all the terms and
provisions of this Sponsor Agreement applicable to a Sponsor.

 

Section 1.15 Certificate
of Amendment. On the date of this Support Agreement, the Company will file the Company Certificate of Amendment with the Delaware
Secretary of State and cause the Company Certificate of Amendment to become effective.

 

ARTICLE
II

REPRESENTATIONS AND WARRANTIES

 

Section 2.1 Representations
and Warranties of each Sponsor. Each Sponsor represents and warrants as of the date hereof (or the date such Sponsor becomes
a party hereto) to Apex and the Company (solely with respect to such Sponsor and not with respect to any other Sponsor) as follows:

 

(a) Organization;
Due Authorization. If such Sponsor is not a natural person, such Sponsor is duly organized, validly existing and in good standing
under the Laws of Delaware, and the execution, delivery and performance of this Sponsor Agreement and the consummation of the transactions
contemplated hereby are within such Sponsor’s corporate powers and have been duly authorized by all necessary corporate actions
on the part of such Sponsor. This Sponsor Agreement has been duly executed and delivered by such Sponsor and, assuming due authorization,
execution and delivery by the other parties to this Sponsor Agreement, this Sponsor Agreement constitutes a legally valid and binding
obligation of such Sponsor, enforceable against such Sponsor in accordance with the terms hereof (subject to the Remedies Exception).
If this Sponsor Agreement is being executed in a representative or fiduciary capacity, the Person signing this Sponsor Agreement
has full power and authority to enter into this Sponsor Agreement on behalf of such Sponsor.

 

     6

     

    

 

(b) Ownership.
Such Sponsor is the record and beneficial owner (as defined in the Securities Act) of, and has good title to, all of the Subject
Securities listed across from such Sponsor’s name on Schedule 1 hereto, and there exist no Liens or any other limitation
or restriction (including any restriction on the right to vote, sell or otherwise dispose of such Subject Securities (other than
transfer restrictions under the Securities Act)) affecting any such Subject Securities, other than Liens pursuant to (i) this Sponsor
Agreement, (ii) the Apex Organizational Documents, (iii) the Business Combination Agreement, (iv) the Voting Letter Agreement or
(v) any applicable securities Laws. The Subject Securities are the only equity securities in Apex owned of record or beneficially
by such Sponsor on the date of this Sponsor Agreement, and none of the Subject Securities held by such Sponsor are subject to any
proxy, voting trust or other agreement or arrangement with respect to the voting of such Subject Securities, except as provided
hereunder and under the Voting Letter Agreement. Such Sponsor has full voting power with respect to the Subject Securities held
by such Sponsor. Other than the Subject Securities held by such Sponsor, such Sponsor does not hold or own any rights to acquire
(directly or indirectly) any equity securities of Apex or any equity securities convertible into, or which can be exchanged for
equity securities of Apex. The Subject Securities held by Apex Sponsor constitute all of the Subject Securities beneficially owned
by the Insider Sponsors as of the date of this Sponsor Agreement.

 

(c) No
Conflicts. The execution and delivery of this Sponsor Agreement by such Sponsor does not, and the performance by such Sponsor
of its obligations hereunder will not, (i) conflict with or result in a violation of the organizational documents of such Sponsor,
(ii) require any consent or approval that has not been given or other action that has not been taken by any Person (including under
any contract binding upon such Sponsor or such Sponsor’s Subject Securities), in each case, to the extent such consent, approval
or other action would prevent, enjoin or materially delay the performance by such Sponsor of its obligations under this Sponsor
Agreement or (iii) conflict with or violate any Law.

 

(d) Litigation.
There are no Actions pending against such Sponsor, or to the knowledge of such Sponsor threatened against such Sponsor, before
(or, in the case of threatened Actions, that would be before) any arbitrator or any Governmental Authority, which in any manner
challenges or seeks to prevent, enjoin or materially delay the performance by such Sponsor of its obligations under this Sponsor
Agreement.

 

(e) Brokerage
Fees. Except as described on Section 5.12 of the Apex Disclosure Schedule, no broker, finder, investment banker or other Person
is entitled to any brokerage fee, finders’ fee or other commission in connection with the transactions contemplated by the
Business Combination Agreement or Apex’s initial public offering based upon arrangements made by such Sponsor, for which
Apex or any of its affiliates may become liable.

 

     7

     

    

 

(f) Loans
and Advances. Such Sponsor represents and warrants that, as of the date hereof, there are no outstanding Working Capital Loans.
Notwithstanding anything herein to the contrary, each Sponsor waives any rights any contract or arrangement to convert all or any
portion of any Working Capital Loans into shares of Apex Class B Common Stock.

 

(g) Affiliate
Arrangements. Except as set forth on Schedule II attached hereto, neither such Sponsor, nor to the knowledge of such
Sponsor, any Person in which such Sponsor has a direct or indirect legal, contractual or beneficial ownership of 5% or greater
is party to, or has any rights with respect to or arising from, any contract with Apex or its Subsidiaries.

 

(h) Acknowledgment.
Such Sponsor understands and acknowledges that each of Apex and the Company is entering into the Business Combination Agreement
in reliance upon such Sponsor’s execution and delivery of this Sponsor Agreement.

 

ARTICLE
III

MISCELLANEOUS

 

Section 3.1 Termination.
This Sponsor Agreement and all of its provisions shall terminate and be of no further force or effect upon the earliest of (a)
the Expiration Time, (b) the liquidation of Apex; provided, that such liquidation occurs after the Expiration Time and the obligations
of Apex are assumed in accordance with Section 1.14herein and (c) the written agreement of the Apex Sponsor, Apex, and the Company.
Upon such termination of this Sponsor Agreement, all obligations of the parties under this Sponsor Agreement will terminate, without
any liability or other obligation on the part of any party hereto to any Person in respect hereof or the transactions contemplated
hereby, and no party hereto shall have any claim against another (and no person shall have any rights against such party), whether
under contract, tort or otherwise, with respect to the subject matter hereof; provided, however, that the termination of this
Sponsor Agreement shall not relieve any party hereto from liability arising in respect of any breach of this Sponsor Agreement
prior to such termination. This ARTICLE III shall survive the termination of this Sponsor Agreement.

 

Section 3.2 Governing
Law. This Sponsor Agreement, and all claims or causes of action (whether in contract or tort) that may be based upon, arise
out of or relate to this Sponsor Agreement or the negotiation, execution or performance of this Sponsor Agreement (including any
claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with
this Sponsor Agreement) will be governed by and construed in accordance with the Laws of the State of Delaware applicable to contracts
executed in and to be performed in that State.

 

     8

     

    

 

Section 3.3 CONSENT
TO JURISDICTION AND SERVICE OF PROCESS; WAIVER OF JURY TRIAL.

 

(a) THE
PARTIES TO THIS SPONSOR AGREEMENT SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE DELAWARE CHANCERY COURT IN RESPECT OF THE INTERPRETATION
AND ENFORCEMENT OF THE PROVISIONS OF THIS SPONSOR AGREEMENT AND ANY RELATED AGREEMENT, CERTIFICATE OR OTHER DOCUMENT DELIVERED
IN CONNECTION HEREWITH AND BY THIS SPONSOR AGREEMENT WAIVE, AND AGREE NOT TO ASSERT, ANY DEFENSE IN ANY ACTION FOR THE INTERPRETATION
OR ENFORCEMENT OF THIS SPONSOR AGREEMENT AND ANY RELATED AGREEMENT, CERTIFICATE OR OTHER DOCUMENT DELIVERED IN CONNECTION HEREWITH,
THAT THEY ARE NOT SUBJECT THERETO OR THAT SUCH ACTION MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SUCH COURTS OR THAT THIS SPONSOR
AGREEMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS OR THAT THEIR PROPERTY IS EXEMPT OR IMMUNE FROM EXECUTION, THAT THE ACTION IS
BROUGHT IN AN INCONVENIENT FORUM, OR THAT THE VENUE OF THE ACTION IS IMPROPER (PROVIDED,
THAT IF JURISDICTION IS NOT THEN AVAILABLE IN THE DELAWARE CHANCERY COURT, THEN ANY SUCH ACTION MAY BE BROUGHT IN ANY FEDERAL COURT
LOCATED IN THE STATE OF DELAWARE OR ANY OTHER DELAWARE STATE COURT). SERVICE OF PROCESS WITH RESPECT THERETO MAY BE MADE UPON ANY
PARTY TO THIS SPONSOR AGREEMENT BY MAILING A COPY THEREOF BY REGISTERED OR CERTIFIED MAIL, POSTAGE PREPAID, TO SUCH PARTY AT ITS
ADDRESS AS PROVIDED IN Section 3.8.

 

(b) WAIVER
OF TRIAL BY JURY. EACH PARTY HERETO HEREBY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS SPONSOR
AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY
WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING
TO THIS SPONSOR AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS SPONSOR AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT
(I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD
NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II) EACH SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF THIS WAIVER, (III) EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (IV) EACH SUCH PARTY HAS BEEN INDUCED TO
ENTER INTO THIS SPONSOR AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section
3.3.

 

Section 3.4 Assignment

 

. This Sponsor Agreement and all of the
provisions hereof will be binding upon and inure to the benefit of the parties hereto and their respective heirs, successors and
permitted assigns. Neither this Sponsor Agreement nor any of the rights, interests or obligations hereunder will be assigned (including
by operation of law) without the prior written consent of the parties hereto.

 

     9

     

    

 

Section 3.5 Specific
Performance. The parties hereto agree that irreparable damage would occur in the event any provision of this Sponsor Agreement
was not performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms
hereof, in addition to any other remedy at law or in equity without the necessity of proving the inadequacy of money damages as
a remedy and without bond or other security being required, this being in addition to any other remedy to which they are entitled
at law or in equity. Each of the parties hereto hereby further acknowledges that the existence of any other remedy contemplated
by this Sponsor Agreement does not diminish the availability of specific performance of the obligations hereunder or any other
injunctive relief. It is accordingly agreed that the parties hereto shall be entitled to seek an injunction or injunctions to
prevent breaches of this Sponsor Agreement and to enforce specifically the terms and provisions of this Sponsor Agreement in the
chancery court or any other state or federal court within the State of Delaware, this being in addition to any other remedy to
which such party is entitled at law or in equity. Each party hereto hereby further agrees that in the event of any action by any
other party for specific performance or injunctive relief, it will not assert that a remedy at law or other remedy would be adequate
or that specific performance or injunctive relief in respect of such breach or violation should not be available on the grounds
that money damages are adequate or any other grounds.  

 

Section 3.6 Amendment.
This Sponsor Agreement may not be amended, changed, supplemented, waived or otherwise modified or terminated, except upon the
execution and delivery of a written agreement executed by Apex, the Company and the Apex Sponsor. Notwithstanding the foregoing,
the Sponsor may update Schedule I attached hereto to list any additional Insider Sponsor who becomes a party to this Sponsor Agreement
pursuant to Section 1.14.

 

Section 3.7 Severability.
If any provision of this Sponsor Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other
provisions of this Sponsor Agreement will remain in full force and effect. Any provision of this Sponsor Agreement held invalid
or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

 

Section 3.8 Notices.
All notices and other communications among the parties hereto shall be in writing and shall be deemed to have been duly given
(a) when delivered in person, (b) when delivered after posting in the United States mail having been sent registered or certified
mail return receipt requested, postage prepaid, (c) when delivered by FedEx or other nationally recognized overnight delivery
service or (d) when e-mailed during normal business hours (and otherwise as of the immediately following Business Day), except,
in each case, if an undelivered message is received by the sender, addressed as follows:

 

If to Apex:

 

Apex Technology Acquisition Corp.

533 Airport Blvd, Suite 400

Burlingame, California 94010

	 	Attention: 	Steve
Fletcher
		Email:	########

 

with a copy to (which will not constitute notice):

 

Latham & Watkins LLP

140 Scott Drive

Menlo Park, California 94025

	 	Attention: 	Josh M. Dubofsky; Brian Paulson; Saad
Khanani
		Email:	########

                                                                  ########

 

     10

     

    

 

If to the Company:

 

AvePoint, Inc.

901 East Byrd Street, Ste. 901

Richmond, Virginia 23219

	 	Attention: 	Brian Brown
		Email:	########

 

with a copy to (which shall not
constitute notice):

 

Cooley LLP

55 Hudson Yards

New York, New York 10001-2157

	 	Attention: 	Mike Lincoln

David Silverman

John McKenna

Brian Leaf
 
		Email:	########

########

########

########

 

If to any Sponsor:

 

Apex Technology Sponsor LLC

c/o Apex Technology Acquisition Corp.

533 Airport Blvd, Suite 400

Burlingame, California 94010

	 	Attention: 	Steve Fletcher
		Email:	########

 

with a copy to (which will not constitute notice):

 

Latham & Watkins LLP

140 Scott Drive

Menlo Park, California 94025

	 	Attention: 	Josh M. Dubofsky; Brian Paulson; Saad
Khanani
		Email:	########

 

Section 3.9 Counterparts.
This Sponsor Agreement may be executed in two or more counterparts (any of which may be delivered by electronic transmission),
each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument.

 

Section 3.10 Capacity.
Each Insider Sponsor is signing this Sponsor Agreement solely in such Insider Sponsor’s capacity as a holder of Subject Securities,
and not in the Insider Sponsor’s capacity as a director, officer or employee of Apex or in the Insider Sponsor’s capacity
as a trustee or fiduciary of any employee benefit plan or trust. Notwithstanding anything herein to the contrary, nothing herein
shall in any way restrict a director or officer of Apex in the exercise of his or her fiduciary duties as a director or officer
of Apex or in his or her capacity as a trustee or fiduciary of any employee benefit plan or trust or prevent or be construed to
create any obligation on the part of any director or officer of Apex or any trustee or fiduciary of any employee benefit plan or
trust from taking any action in his or her capacity as such director, officer, trustee or fiduciary, provided that nothing contained
in this Section 3.10 shall obviate any of such Insider Sponsor’s Stockholder’s obligations under Article 1 of this
Sponsor Agreement.

 

Section 3.11 Entire
Agreement. This Sponsor Agreement and the agreements referenced herein constitute the entire agreement and understanding of
the parties hereto in respect of the subject matter hereof and supersede all prior understandings, agreements or representations
by or among the parties hereto to the extent they relate in any way to the subject matter hereof.

 

[THE REMAINDER OF THIS PAGE
IS INTENTIONALLY BLANK]

 

     11

     

    

 

IN WITNESS WHEREOF,
the Sponsors, Apex, and the Company have each caused this Sponsor Support Agreement to be duly executed as of the date first written
above.

 

	 	APEX SPONSOR:
	 	 	 
	 	APEX TECHNOLOGY SPONSOR LLC
	 	 	 
	 	By:	/s/ Jeff Epstein
	 	 	Name: 	Jeff Epstein
	 	 	Title:	Co-Chief Executive Officer, Chief Financial Officer and Secretary
	 	 	 
	 	APEX:
	 	 	 
	 	APEX TECHNOLOGY ACQUISITION CORP.
	 	 	 
	 	By:	/s/ Jeff Epstein
	 	 	Name:	Jeff Epstein
	 	 	Title:	Co-Chief Executive Officer, Chief Financial Officer and Secretary

 

 

[Signature Page to Sponsor Support Agreement]

 

     

     

    

 

	 	COMPANY:
	 	 	 
	 	AVEPOINT, INC.
	 	 	 
	 	By: 	/s/ Brian Brown
	 	 	Name: 	Brian Brown
	 	 	Title:	Chief Legal Counsel and Chief Operating Officer

 

 

[Signature Page to Sponsor Support Agreement]Exhibit 10.7

 

EXECUTION VERSION

 

SUBSCRIPTION AGREEMENT

 

This SUBSCRIPTION AGREEMENT
(this “Subscription Agreement”) is entered into on November 23, 2020, by and between Apex Technology Acquisition
Corp., a Delaware corporation (“Apex”), and the undersigned subscriber (the “Investor”).

 

WHEREAS, this Subscription
Agreement is being entered into in connection with the Business Combination Agreement and Plan of Reorganization, dated as of the
date hereof (as may be amended, supplemented or otherwise modified from time to time, the “Transaction Agreement”),
by and among Apex, AvePoint, Inc., a Delaware corporation (the “Company”), Athena Technology Merger Sub, Inc.,
a Delaware corporation (“Merger Sub 1”), Athena Technology Merger Sub 2, LLC, a Delaware limited liability company
(“Merger Sub 2”) and the other parties thereto, pursuant to which, among other things, Merger Sub 1 will
merge with and into the Company (the “First Merger”), with the Company surviving the First Merger as a wholly
owned subsidiary of Apex, and, promptly following the First Merger, the surviving Company will merge with and into Merger Sub 2,
with Merger Sub 2 surviving as a wholly owned subsidiary of Apex, on the terms and subject to the conditions therein (together,
the “Transaction”);

 

WHEREAS, in connection
with the Transaction, Apex is seeking commitments from interested investors to purchase, prior to the closing of the Transaction,
shares of Apex’s Class A common stock, par value $0.0001 per share, (the “Shares”) in a private placement
for a purchase price of $10.00 per share (the “Per Share Subscription Price”);

 

WHEREAS, the aggregate
purchase price to be paid by the Investor for the subscribed Shares (as set forth on the signature page hereto) is referred
to herein as the “Subscription Amount;” and

 

WHEREAS, substantially
concurrently with the execution of this Subscription Agreement, Apex is entering into separate subscription agreements
substantially similar to this Subscription Agreement (collectively, the “Other Subscription Agreements”) with
certain investors with an aggregate purchase price of $140,000,000.00 (inclusive of the Subscription Amount) (the “PIPE
Investment”).

 

NOW, THEREFORE, in
consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth
herein, and intending to be legally bound hereby, each of the Investor and Apex acknowledges and agrees as follows:

 

1. Subscription.
The Investor hereby irrevocably subscribes for and agrees to purchase from Apex the number of Shares set forth on the signature
page of this Subscription Agreement on the terms and subject to the conditions provided for herein.

 

2. Closing.
The closing of the sale of the Shares contemplated hereby (the “Closing”) shall occur on the closing date (the
“Closing Date”) and be conditioned upon the prior or substantially concurrent consummation of the Transaction
(the "Transaction Closing"). Upon delivery of written notice from (or on behalf of) Apex to the Investor (the
“Closing Notice”), that Apex reasonably expects all conditions to the closing of the Transaction to be satisfied
or waived on an expected closing date that is not less than five (5) business days from the date on which the Closing Notice
is delivered to the Investor, the Investor shall deliver to Apex, three (3) business days prior to the expected closing date
specified in the Closing Notice, the Subscription Amount by wire transfer of United States dollars in immediately available funds
to the account(s) specified by Apex in the Closing Notice. On or prior to the Closing Date, Apex shall issue the Shares
to the Investor and subsequently cause the Shares to be registered in book entry form in the name of the Investor on Apex’s
share register, which book entry records shall contain an appropriate notation or legend concerning transfer restrictions of the
Shares, in accordance with any applicable securities laws of the states of the United States and other applicable jurisdictions.
For purposes of this Subscription Agreement, “business day” shall mean a day, other than a Saturday, Sunday or other
day on which commercial banks in New York, New York are authorized or required by law to close. Prior to or at the Closing, Investor
shall deliver to Apex a duly completed and executed Internal Revenue Service Form W-9 or appropriate Form W-8. In the
event the Closing Date does not occur within three (3) business days after the expected closing date specified in the Closing
Notice, Apex shall promptly (but not later than two (2) business days thereafter) return the Subscription Amount to the
Investor by wire transfer of U.S. dollars in immediately available funds to the account specified by the Investor, and any book-entries
for the Shares shall be deemed cancelled; provided that, unless this Subscription Agreement has been terminated pursuant
to Section 8 hereof, such return of funds shall not terminate this Subscription Agreement or relieve the Investor of
its obligation to purchase the Shares at the Closing.

 

     

     

    

 

3. Closing
Conditions. The obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription
Agreement is subject to the following conditions:

 

(a) no governmental
authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or regulation (whether temporary,
preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated hereby
illegal or otherwise preventing or prohibiting consummation of the transactions contemplated hereby, and no governmental authority
shall have instituted or threatened in writing a proceeding seeking to impose any such prevention or prohibition;

 

(b) the terms of the
Transaction Agreement (including the conditions thereto) shall not have been amended or waived in a manner that is materially adverse
to the Investor (in its capacity as such);

 

(c) (i) with respect
to Investor’s obligation to consummate the purchase of the Shares pursuant to this Subscription Agreement, all representations
and warranties of Apex contained in this Subscription Agreement shall be true and correct in all material respects (other than
representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which representations
and warranties shall be true in all respects) at and as of the Closing Date, and consummation of the Closing shall constitute a
reaffirmation by Apex of each of the representations, warranties and agreements of Apex contained in this Subscription Agreement
as of the Closing Date (other than those representations and warranties expressly made as of an earlier date, which shall be true
and correct in all material respects as of such earlier date); and (ii) with respect to Apex’s obligation to consummate the
sale of the Shares pursuant to this Subscription Agreement, all representations and warranties of Investor contained in this Subscription
Agreement shall be true and correct in all material respects (other than representations and warranties that are qualified as to
materiality or Material Adverse Effect (as defined herein), which representations and warranties shall be true in all respects)
at and as of the Closing Date, and consummation of the Closing shall constitute a reaffirmation by Investor of each of the representations,
warranties and agreements of Investor contained in this Subscription Agreement as of the Closing Date (other than those representations
and warranties expressly made as of an earlier date, which shall be true and correct in all material respects as of such earlier
date);

 

(d) (i) with respect
to Investor’s obligation to consummate the purchase of the Shares pursuant to this Subscription Agreement, Apex shall have
performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by this Subscription
Agreement to be performed, satisfied or complied with by it at or prior to the Closing, except where the failure of such performance
or compliance would not or would not reasonably be expected to prevent, materially delay, or materially impair the ability of Investor
to consummate the Closing; and (ii) with respect to Apex’s obligation to consummate the sale of the Shares pursuant to this
Subscription Agreement, Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing,
except where the failure of such performance or compliance would not or would not reasonably be expected to prevent, materially
delay, or materially impair the ability of Apex to consummate the Closing; and

 

(e) all conditions
precedent to the closing of the Transaction, including all necessary approvals of Apex’s stockholders and regulatory approvals,
if any, shall have been satisfied or waived (other than those conditions that may only be satisfied at the closing of the Transaction,
but subject to satisfaction or waiver of such conditions as of the closing of the Transaction).

 

4. Further
Assurances. At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional
actions as the parties reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated
by this Subscription Agreement.

 

     2

     

    

 

5. Apex
Representations and Warranties. Apex represents and warrants to the Investor, as of the date hereof and as of the Closing Date,
that:

 

(a) Apex
is duly incorporated, validly existing as a corporation and in good standing under the laws of the State of Delaware. Apex has
all power (corporate or otherwise) and authority to own, lease and operate its properties and conduct its business as presently
conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.

 

(b) As
of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor
in accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable and
will not have been issued in violation of or subject to any preemptive or similar rights created under Apex’s certificate
of incorporation (as in effect at such time of issuance) or under the Delaware General Corporation Law.

 

(c) This
Subscription Agreement has been duly authorized, executed and delivered by Apex and, assuming that this Subscription Agreement
constitutes the valid and binding agreement of the Investor, this Subscription Agreement is enforceable against Apex in accordance
with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium or other laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether
considered at law or equity.

 

(d) The
issuance and sale by Apex of the Shares pursuant to this Subscription Agreement will not conflict with or result in a breach or
violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien,
charge or encumbrance upon any of the property or assets of Apex or any of its subsidiaries pursuant to the terms of (i) any
indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Apex or any of its
subsidiaries is a party or by which Apex or any of its subsidiaries is bound or to which any of the property or assets of Apex
is subject that would reasonably be expected to have a material adverse effect on the business, financial condition or results
of operations of Apex and its subsidiaries, taken as a whole (a “Material Adverse Effect”), or materially affect
the validity of the Shares or the legal authority of Apex to comply in all material respects with its obligations under this Subscription
Agreement; (ii) result in any violation of the provisions of the organizational documents of Apex; or (iii) result in
any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic
or foreign, having jurisdiction over Apex or any of its properties that would reasonably be expected to have a Material Adverse
Effect or materially affect the validity of the Shares or the legal authority of Apex to comply in all material respects with its
obligations under this Subscription Agreement.

 

(e) As
of their respective filing dates, all reports required to be filed by Apex with the U.S. Securities and Exchange Commission (the
“SEC”) since September 20, 2019 (the “SEC Reports”) complied in all material respects with
the applicable requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the
rules and regulations of the SEC promulgated thereunder. There are no material outstanding or unresolved comments in comment
letters received by Apex from the staff of the Division of Corporation Finance of the SEC with respect to any of the SEC Reports.
As of the date hereof, none of the SEC Reports filed under the Exchange Act contained, when filed and as amended to the date hereof,
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements made therein, in the light of the circumstances under which they were made, not misleading, and such SEC
reports complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC promulgated
thereunder. Apex has timely filed each report, statement, schedule, prospectus, and registration statement that Apex was required
to file with the SEC since its initial registration of the Shares with the SEC.

 

(f) Apex
is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in
connection with the issuance of the Shares pursuant to this Subscription Agreement, other than (i)  filings with the SEC,
(ii) filings required by applicable state securities laws, (iii) the filings required in accordance with Section 13
of this Subscription Agreement; (iv) those required by Nasdaq, including with respect to obtaining approval of Apex’s
stockholders, and (v) the failure of which to obtain would not be reasonably be expected to have, individually or in the aggregate,
a Material Adverse Effect.

 

(g) Apex
is in compliance with all applicable laws, except where such noncompliance would not reasonably be expected to have a Material
Adverse Effect. As of the date hereof, Apex has not received any written communication from a governmental authority that
alleges that Apex is not in compliance with or is in default or violation of any applicable law, except where such non-compliance,
default or violation would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

     3

     

    

 

(h) Assuming
the accuracy of the Investor’s representations and warranties set forth in Section 6 of this Subscription Agreement,
no registration under the Securities Act of 1933, as amended (the “Securities Act”), is required for the offer
and sale of the Shares by Apex to the Investor.

 

(i) Neither
Apex nor any person acting on its behalf has offered or sold the Shares by any form of general solicitation or general advertising
in violation of the Securities Act.

 

(j) As
of the date hereof, the issued and outstanding Class A common stock of Apex are registered pursuant to Section 12(b) of
the Exchange Act; and are listed for trading on The Nasdaq Stock Market LLC. There is no suit, action, proceeding or investigation
pending or, to the knowledge of Apex, threatened against Apex by The Nasdaq Stock Market LLC or the SEC with respect to any intention
by such entity to deregister the Shares or prohibit or terminate the listing of the Shares on The Nasdaq Stock Market LLC. Apex
has taken no action that is designed to terminate the registration of the Shares under the Exchange Act.

 

(k) Apex
is not under any obligation to pay any broker’s fee or commission in connection with the sale of the Shares other than to
the Placement Agents (as defined below).

 

(l) The
Other Subscription Agreements reflect the same Per Share Subscription Price and other terms with respect to the purchase of the
Shares that are no more favorable to such subscriber thereunder than the terms of this Subscription Agreement, other than terms
particular to the regulatory requirements of such subscriber or its affiliates or related funds.

 

(m) Apex is not, and
immediately after receipt of payment for the Shares, will not be, an “investment company” within the meaning of the
Investment Company Act of 1940, as amended.

 

6. Investor
Representations and Warranties. The Investor represents and warrants to Apex, as of the date hereof and as of the Closing date,
that:

 

(a) The
Investor (i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an
institutional “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3), (7) or (8) under
the Securities Act), in each case, satisfying the applicable requirements set forth on Schedule A, (ii) is acquiring
the Shares only for his, her or its own account and not for the account of others, or if the Investor is subscribing for the Shares
as a fiduciary or agent for one or more investor accounts, the Investor has full investment discretion with respect to each such
account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of each
owner of each such account, and (iii) is not acquiring the Shares with a view to, or for offer or sale in connection with,
any distribution thereof in violation of the Securities Act (and shall provide the requested information set forth on Schedule A).
The Investor is not an entity formed for the specific purpose of acquiring the Shares.

 

(b) The
Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the
meaning of the Securities Act, that the Shares have not been registered under the Securities Act and that Apex is not required
to register the Shares except as set forth in Section 7 of this Subscription Agreement. The Investor acknowledges and
agrees that the Shares may not be offered, resold, transferred, pledged or otherwise disposed of by the Investor absent an effective
registration statement under the Securities Act except (i) to Apex or a subsidiary thereof, (ii) to non-U.S. persons
pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or
(iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and, in each case,
in accordance with any applicable securities laws of the states of the United States and other applicable jurisdictions, and that
any certificates or book entry records representing the Shares shall contain a restrictive legend to such effect (provided that
such legends will be eligible for removal upon compliance with the relevant resale provisions of Rule 144). The Investor acknowledges
and agrees that the Shares will be subject to these securities law transfer restrictions and, as a result of these transfer restrictions,
the Investor may not be able to readily offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required
to bear the financial risk of an investment in the Shares for an indefinite period of time. The Investor acknowledges and agrees
that the Shares will not immediately be eligible for offer, resale, transfer, pledge or disposition pursuant to Rule 144 promulgated
under the Securities Act, and that the provisions of Rule 144(i) will apply to the Shares. The Investor acknowledges
and agrees that it has been advised to consult legal, tax and accounting prior to making any offer, resale, transfer, pledge or
disposition of any of the Shares.

 

     4

     

    

 

(c) The
Investor acknowledges and agrees that the Investor is purchasing the Shares from Apex. The Investor further acknowledges that there
have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of Apex, the Company, any
of their respective affiliates or any control persons, officers, directors, employees, agents or representatives of any of the
foregoing or any other person or entity, expressly or by implication, other than those representations, warranties, covenants and
agreements of Apex expressly set forth in Section 5 of this Subscription Agreement.

 

(d) The
Investor acknowledges and agrees that the Investor has received such information as the Investor deems necessary in order to make
an investment decision with respect to the Shares, including, with respect to Apex, the Transaction and the business of the Company
and its subsidiaries. Without limiting the generality of the foregoing, the Investor acknowledges that he, she or it has reviewed
Apex’s filings with the SEC. The Investor acknowledges and agrees that the Investor and the Investor’s professional
advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as the
Investor and such Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect
to the Shares.

 

(e) The
Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and Apex, the Company
or a representative of Apex or the Company, and the Shares were offered to the Investor solely by direct contact between the Investor
and Apex, the Company or a representative of Apex or the Company. The Investor did not become aware of this offering of the Shares,
nor were the Shares offered to the Investor, by any other means. The Investor acknowledges that the Shares (i) were not offered
by any form of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering
under, or in a distribution in violation of, the Securities Act, or any state securities laws. The Investor acknowledges that it
is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation
(including, without limitation, Apex, the Company, the Placement Agents, any of their respective affiliates or any control
persons, officers, directors, employees, agents or representatives of any of the foregoing), other than the representations and
warranties of Apex contained in Section 5 of this Subscription Agreement, in making its investment or decision to invest
in Apex.

 

(f) The
Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including
those set forth in Apex’s filings with the SEC. The Investor has such knowledge and experience in financial and business
matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor has sought such accounting,
legal and tax advice as the Investor has considered necessary to make an informed investment decision. The Investor acknowledges
that Investor shall be responsible for any of the Investor’s tax liabilities that may arise as a result of the transactions
contemplated by this Subscription Agreement, and that neither Apex nor the Company has provided any tax advice or any other representation
or guarantee regarding the tax consequences of the transactions contemplated by the Subscription Agreement.

 

(g) Alone,
or together with any professional advisor(s), the Investor has been furnished with all materials that it considers relevant to
an investment in the Shares, has had a full opportunity to ask questions of and receive answers from Apex or any person or persons
acting on behalf of Apex concerning the terms and conditions of an investment in the Shares, has adequately analyzed and fully
considered the risks of an investment in the Shares and determined that the Shares are a suitable investment for the Investor and
that the Investor is able at this time and in the foreseeable future to bear the economic risk of a total loss of the Investor’s
investment in Apex. The Investor acknowledges specifically that a possibility of total loss exists.

 

(h) In
making its decision to purchase the Shares, the Investor has relied solely upon independent investigation made by the Investor
and the representations and warranties in Section 5. Without limiting the generality of the foregoing, the Investor
has not relied on any statements or other information provided by or on behalf of the Placement Agents or any of their respective
affiliates or any control persons, officers, directors, employees, agents or representatives of any of the foregoing concerning
Apex, the Company, the Transaction, the Transaction Agreement, this Subscription Agreement or the transactions contemplated hereby
or thereby, the Shares or the offer and sale of the Shares.

 

     5

     

    

 

(i) The
Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the
Shares or made any findings or determination as to the fairness of this investment.

 

(j) The
Investor, if not a natural person, has been duly formed or incorporated and is validly existing and is in good standing under the
laws of its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its obligations
under this Subscription Agreement.

 

(k) The
execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the Investor, have
been duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation
of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the
Investor is a party or by which the Investor is bound, and, if the Investor is not a natural person, will not violate any provisions
of the Investor’s organizational documents, including, without limitation, its incorporation or formation papers, bylaws,
indenture of trust or partnership or operating agreement, as may be applicable. The signature of the Investor on this Subscription
Agreement is genuine, and the signatory, if the Investor is a natural person, has legal competence and capacity to execute the
same or, if the Investor is not a natural person, the signatory has been duly authorized to execute the same, and, assuming that
this Subscription Agreement constitutes the valid and binding agreement of Apex, this Subscription Agreement constitutes a legal,
valid and binding obligation of the Investor, enforceable against the Investor in accordance with its terms except as may be limited
or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating
to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

(l) Neither
the Investor nor, if the Investor is not a natural person, any of its officers, directors, managers, managing members, general
partners or any other person acting in a similar capacity or carrying out a similar function, is (i) a person named on the
Specially Designated Nationals and Blocked Persons List, the Foreign Sanctions Evaders List, the Sectoral Sanctions Identification
List, or any other similar list of sanctioned persons administered by the U.S. Treasury Department’s Office of Foreign Assets
Control (“OFAC”), or any similar list of sanctioned persons administered by the European Union or any individual
European Union member state, including the United Kingdom (collectively, “Sanctions Lists”); (ii) directly
or indirectly owned or controlled by, or acting on behalf of, one or more persons on a Sanctions List; (iii) organized, incorporated,
established, located, resident in, or a citizen, national, or the government, including any political subdivision, agency, or instrumentality
thereof, of, Cuba, Iran, North Korea, Syria, Venezuela, the Crimea region of Ukraine, or any other country or territory embargoed
or subject to substantial trade restrictions by the United States, the European Union or any individual European Union member state,
including the United Kingdom; (iv) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515;
or (v) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank (collectively, a “Prohibited
Investor”). The Investor represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C.
Section 5311 et seq.) (the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”),
and its implementing regulations (collectively, the “BSA/PATRIOT Act”), that the Investor maintains policies
and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. The Investor also represents
that it maintains policies and procedures reasonably designed to ensure compliance with sanctions administered by the United States,
the European Union, or any individual European Union member state, including the United Kingdom, to the extent applicable to it.
The Investor further represents that the funds held by the Investor and used to purchase the Shares were legally derived and were
not obtained, directly or indirectly, from a Prohibited Investor.

 

     6

     

    

 

(m) If
the Investor is or is acting on behalf of (i) an employee benefit plan that is subject to Title I of the Employee Retirement
Income Security Act of 1974, as amended (“ERISA”), (ii) a plan, an individual retirement account or other
arrangement that is subject to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”),
(iii) an entity whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement
described in clauses (i) and (ii) (each, an “ERISA Plan”), or (iv) an employee benefit plan
that is a governmental plan (as defined in Section 3(32) of ERISA), a church plan (as defined in Section 3(33) of ERISA),
a non-U.S. plan (as described in Section 4(b)(4) of ERISA) or other plan that is not subject to the foregoing clauses (i),
(ii) or (iii) but may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations
that are similar to such provisions of ERISA or the Code (collectively, “Similar Laws,” and together with ERISA
Plans, “Plans”), the Investor represents and warrants that (A) neither Apex nor any of its affiliates (the
“Transaction Parties”) has provided investment advice or has otherwise acted as the Plan’s fiduciary,
with respect to its decision to acquire and hold the Shares, and none of the parties to the Transaction is or shall at any time
be the Plan’s fiduciary with respect to any decision in connection with the Investor’s investment in the Shares; and
(B) its purchase of the Shares will not result in a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975
of the Code, or any applicable Similar Law.

 

(n) No
disclosure or offering document has been prepared by any of Goldman Sachs & Co. LLC, Citigroup Global Markets Inc., Evercore
Group L.L.C., or any of their respective affiliates (collectively, the “Placement Agents”) in connection with
the offer and sale of the Shares.

 

(o) None
of the Placement Agents, nor any of their respective affiliates, nor any control persons, officers, directors, employees, partners,
agents or representatives of any of the foregoing has made any independent investigation with respect to Apex, the Company or their
respective subsidiaries or any of their respective businesses, or the Shares or the accuracy, completeness or adequacy of any information
supplied to the Investor by Apex.

 

(p) In
connection with the issue and purchase of the Shares, none of the Placement Agents have acted as the Investor’s financial
advisor or fiduciary.

 

(q) The
Investor has or has commitments to have and, when required to deliver payment to Apex pursuant to Section 2 above,
will have, sufficient funds to pay the Subscription Amount and consummate the purchase and sale of the Shares pursuant to this
Subscription Agreement.

 

(s) The
Investor acknowledges that the purchase and sale of Shares hereunder meets the exemptions from filing under FINRA Rule 5123(b)(1).

 

(t)  The
Investor acknowledges that the Placement Agents may have acquired, or may acquire, non-public information with respect to Apex,
which the Investor agrees need not be provided to it.

 

7. Registration
Rights.

 

(a) Apex
agrees that, within fifteen (15) business days following the Closing Date (such deadline, the “Filing Deadline”), Apex
will submit to or file with the SEC a registration statement for a shelf registration on Form S-1 or Form S-3 (if the
Company is then eligible to use a Form S-3 shelf registration) (the “Registration Statement”), in each
case, covering the resale of the Shares acquired by the Investor pursuant to this Agreement which are eligible for registration
(determined as of two (2) business days prior to such submission or filing) (the “Registrable Shares”)
and Apex shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable
after the filing thereof, but no later than the earlier of (i) the 90th calendar day following the filing date thereof if
the SEC notifies Apex that it will “review” the Registration Statement and (ii) the 10th business day after the
date Apex is notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed”
or will not be subject to further review (such earlier date, the “Effectiveness Deadline”); provided, however,
that Apex’s obligations to include the Registrable Shares in the Registration Statement are contingent upon Investor furnishing
in writing to Apex such information regarding Investor, the securities of Apex held by Investor and the intended method of disposition
of the Registrable Shares (which shall be limited to non-underwritten public offerings) as shall be reasonably requested by Apex
to effect the registration of the Registrable Shares, and Investor shall execute such documents in connection with such registration
as Apex may reasonably request that are customary of a selling stockholder in similar situations, including providing that Apex
shall be entitled to postpone and suspend the effectiveness or use of the Registration Statement, if applicable, during any customary
blackout or similar period or as permitted hereunder; provided that Investor shall not in connection with the foregoing
be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability to
transfer the Registrable Shares. For as long as the Investor holds Shares, Apex will use commercially reasonable efforts to
file all reports for so long as the condition in Rule 144(c)(1) (or Rule 144(i)(2), if applicable) is required to
be satisfied, and provide all customary and reasonable cooperation, necessary to enable the undersigned to resell the Shares pursuant
to Rule 144 of the Securities Act (in each case, when Rule 144 of the Securities Act becomes available to the Investors).
Apex will provide a draft of the Registration Statement to Investor for review at least two (2) business days in advance of filing
the Registration Statement. In no event shall the Investor be identified as a statutory underwriter in the Registration Statement
unless requested by the SEC; provided, that if the SEC requests that the Investor be identified as a statutory underwriter
in the Registration Statement, the Investor will have an opportunity to withdraw its Shares from the Registration Statement. Any
failure by Apex to file the Registration Statement by the Filing Deadline or to effect such Registration Statement by the Effectiveness
Deadline shall not otherwise relieve Apex of its obligations to file or effect the Registration Statement as set forth above in
this Section 7.

 

     7

     

    

 

(b) At
its expense Apex shall:

 

(i) except
for such times as Apex is permitted hereunder to suspend the use of the prospectus forming part of a Registration Statement, use
its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities
laws which Apex determines to obtain, continuously effective with respect to Investor, and to keep the applicable Registration
Statement or any subsequent shelf registration statement free of any material misstatements or omissions, until the earlier of
the following: (A) Investor ceases to hold any Registrable Shares, (B) the date all Registrable Shares held by Investor
may be sold without restriction under Rule 144, including without limitation, any volume and manner of sale restrictions which
may be applicable to affiliates under Rule 144 and without the requirement for Apex to be in compliance with the current public
information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable), and (C) two years from the date
of effectiveness of the Registration Statement. The period of time during which Apex is required hereunder to keep a Registration
Statement effective is referred to herein as the “Registration Period”;

 

(ii) advise
Investor, as expeditiously as practicable:

 

(1) when
a Registration Statement or any amendment thereto has been filed with the SEC;

 

(2) after
it shall receive notice or obtain knowledge thereof, of the issuance by the SEC of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for such purpose;

 

(3) of
the receipt by Apex of any notification with respect to the suspension of the qualification of the Registrable Shares included
therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and

 

(4) subject
to the provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in any
Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to state
a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the
light of the circumstances under which they were made) not misleading.

 

Notwithstanding anything to the contrary
set forth herein, Apex shall not, when so advising Investor of such events, provide Investor with any material, nonpublic
information regarding Apex other than to the extent that providing notice to Investor of the occurrence of the events listed in
(1) through (4) above constitutes material, nonpublic information regarding Apex; 

 

(iii) use
its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any Registration Statement
as soon as reasonably practicable;

 

     8

     

    

 

(iv) upon
the occurrence of any event contemplated in Section 7(b)(ii)(4) above, except for such times as Apex is permitted
hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, Apex shall use
its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective amendment to such Registration
Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers
of the Registrable Shares included therein, such prospectus will not include any untrue statement of a material fact or omit to
state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made,
not misleading;

 

(v) use
its commercially reasonable efforts to cause all Registrable Shares to be listed on each securities exchange or market, if any,
on which the Class A Shares issued by Apex have been listed;

 

(vi) use
its commercially reasonable efforts to allow the Investor to review disclosure regarding the Investor in the Registration Statement;
and

 

(vii) otherwise,
in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Investor, consistent
with the terms of this Agreement, in connection with the registration of the Registrable Shares.

 

(c) Notwithstanding
anything to the contrary in this Subscription Agreement, Apex shall be entitled to delay the filing or effectiveness of, or
suspend the use of, the Registration Statement if it determines that in order for the Registration Statement not to contain a material
misstatement or omission, (i) an amendment thereto would be needed to include information that would at that time not otherwise
be required in a current, quarterly, or annual report under the Exchange Act, (ii) the negotiation or consummation of a transaction
by Apex or its subsidiaries is pending or an event has occurred, which negotiation, consummation or event Apex’s board of
directors reasonably believes would require additional disclosure by Apex in the Registration Statement of material information
that Apex has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement
would be expected, in the reasonable determination of Apex’s board of directors to cause the Registration Statement to fail
to comply with applicable disclosure requirements, or (iii) in the good faith judgment of the majority of Apex’s board
of directors, such filing or effectiveness or use of such Registration Statement, would be seriously detrimental to the Company
and the majority of the Apex board or directors concludes as a result that it is essential to defer such filing (each such circumstance,
a “Suspension Event”); provided, however, that Apex may not delay or suspend the Registration Statement
on more than three occasions or for more than ninety (90) consecutive calendar days, or more than one hundred and twenty (120)
total calendar days in each case during any twelve-month period. Upon receipt of any written notice from Apex of the happening
of any Suspension Event during the period that the Registration Statement is effective or if as a result of a Suspension Event
the Registration Statement or related prospectus contains any untrue statement of a material fact or omits to state any material
fact required to be stated therein or necessary to make the statements therein (in light of the circumstances under which they
were made, in the case of the prospectus) not misleading, Investor agrees that (i) it will immediately discontinue offers
and sales of the Registrable Shares under the Registration Statement (excluding, for the avoidance of doubt, sales conducted pursuant
to Rule 144) until Investor receives copies of a supplemental or amended prospectus (which Apex agrees to promptly prepare)
that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment
has become effective or unless otherwise notified by Apex that it may resume such offers and sales, and (ii) it will maintain
the confidentiality of any information included in such written notice delivered by Apex unless otherwise required by law or subpoena.
If so directed by Apex, Investor will deliver to Apex or, in Investor’s sole discretion destroy, all copies of the prospectus
covering the Registrable Shares in Investor’s possession; provided, however, that this obligation to deliver or destroy
all copies of the prospectus covering the Registrable Shares shall not apply (A) to the extent Investor is required to retain
a copy of such prospectus (1) in order to comply with applicable legal, regulatory, self-regulatory or professional requirements
or (2) in accordance with a bona fide pre-existing document retention policy or (B) to copies stored electronically on
archival servers as a result of automatic data back-up.

 

     9

     

    

 

(d) Indemnification.

 

(i) Apex
agrees to indemnify, to the extent permitted by law, Investor (to the extent a seller under the Registration Statement), its
directors and officers and each person who controls Investor (within the meaning of the Securities Act), to the extent permitted
by law, against all losses, claims, damages, liabilities and reasonable and documented out of pocket expenses (including reasonable
and documented attorneys’ fees of one law firm) caused by any untrue or alleged untrue statement of material fact contained
in any Registration Statement, prospectus included in any Registration Statement (“Prospectus”) or preliminary
Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under
which they were made) not misleading, except insofar as the same are caused by or contained in any information or affidavit so
furnished in writing to Apex by or on behalf of such Investor expressly for use therein.

 

(ii) In
connection with any Registration Statement in which an Investor is participating, such Investor shall furnish (or cause to be furnished)
to Apex in writing such information and affidavits as Apex reasonably requests for use in connection with any such Registration
Statement or Prospectus and, to the extent permitted by law, shall indemnify Apex, its directors and officers and each person or
entity who controls Apex (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and expenses
(including, without limitation, reasonable outside attorneys’ fees) resulting from any untrue or alleged untrue statement
of material fact contained or incorporated by reference in any Registration Statement, Prospectus or preliminary Prospectus or
any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein
or necessary to make the statements therein (in the case of a Prospectus, in the light of the circumstances under which they were
made) not misleading, but only to the extent that such untrue statement or omission is contained (or not contained in, in the case
of an omission) in any information or affidavit so furnished in writing by on behalf of such Investor expressly for use therein;
provided, however, that the liability of each such Investor shall be several and not joint and shall be in proportion to
and limited to the net proceeds received by such Investor from the sale of Registrable Shares giving rise to such indemnification
obligation.

 

(iii) Any
person or entity entitled to indemnification herein shall (A) give prompt written notice to the indemnifying party of any
claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any
person’s or entity’s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying
party) and (B) unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified
and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim
with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be
subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably
withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated
to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such
claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party
and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified
party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment
of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes
a statement or admission of fault and culpability on the part of such indemnified party or which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such
claim or litigation.

 

(iv) The
indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation
made by or on behalf of the indemnified party or any officer, director or controlling person or entity of such indemnified party
and shall survive the transfer of securities.

 

     10

     

    

 

(v) If
the indemnification provided under this Section 7(d) from the indemnifying party is unavailable or insufficient
to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then
the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified
party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the
relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations; provided,
however, the liability of the Investor shall be limited to the net proceeds received by such Investor from the sale of Registrable
Shares giving rise to such indemnification obligation. The relative fault of the indemnifying party and indemnified party shall
be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement
of a material fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission),
or relates to information supplied by (or not supplied by, in the case of an omission), such indemnifying party or indemnified
party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity
to correct or prevent such action. The amount paid or payable by a party as a result of the losses or other liabilities referred
to above shall be deemed to include, subject to the limitations set forth in Sections 7(d)(i), (ii) and (iii) above,
any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution pursuant to this Section 7(d)(v) from any person or entity who was not guilty of such
fraudulent misrepresentation.

 

8. Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the
parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest
to occur of (i) such date and time as the Transaction Agreement is terminated in accordance with its terms, (ii) upon
the mutual written agreement of each of the parties hereto (and the Company) to terminate this Subscription Agreement, (iii) if
the conditions to Closing set forth in Section 3 of this Subscription Agreement are not satisfied, or are not capable
of being satisfied, on or prior to the Closing and, as a result thereof, the transactions contemplated by this Subscription Agreement
will not be or are not consummated at the Closing and (iv) written notice by either party to the other party to terminate this
Subscription Agreement if the transactions contemplated by this Subscription Agreement are not consummated on or prior to the date
that is 180 days after the date of the Transaction Agreement; provided that nothing herein will relieve any party from liability
for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity
to recover losses, liabilities or damages arising from any such willful breach. Apex shall notify the Investor of the termination
of the Transaction Agreement promptly after the termination of such agreement. Upon the termination of this Subscription Agreement
in accordance with this Section 8, any monies paid by the Investor to Apex in connection herewith shall be promptly
(and in any event within one business day after such termination) returned to the Investor.

 

9. Investor
Covenant. Investor hereby agrees that, from the date of this Subscription Agreement, none of Investor, its controlled affiliates,
or any person or entity acting on behalf of Investor or any of its controlled affiliates or pursuant to any understanding with
Investor or any of its controlled affiliates will engage in any Short Sales with respect to securities of the Apex prior to the
Closing. For purposes of this Section 9, “Short Sales” shall include, without limitation, all “short sales”
as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges
(other than pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options,
puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions through non-U.S.
broker dealers or foreign regulated brokers. Notwithstanding the foregoing, (i) nothing herein shall prohibit other entities under
common management with Investor that have no knowledge of this Subscription Agreement or of Investor’s participation in the
Transaction or PIPE Investment (including Investor’s controlled affiliates and/or affiliates) from entering into any Short
Sales and (ii) in the case of an Investor that is a multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such Investor’s assets and the portfolio managers have no knowledge of the investment decisions made
by the portfolio managers managing other portions of such Investor’s assets, the covenant set forth above shall only apply
with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Shares
covered by this Subscription Agreement.

 

     11

     

    

 

10. Trust
Account Waiver. The Investor acknowledges that Apex is a blank check company with the powers and privileges to effect a merger,
asset acquisition, reorganization or similar business combination involving Apex and one or more businesses or assets. The Investor
further acknowledges that, as described in Apex’s prospectus relating to its initial public offering dated September 16,
2019 (the “Apex Prospectus”) available at www.sec.gov, substantially all of Apex’s assets consist of the
cash proceeds of Apex’s initial public offering and private placement of its securities, and substantially all of those proceeds
have been deposited in a trust account (the “Trust Account”) for the benefit of Apex, its public shareholders
and the underwriters of Apex’s initial public offering. Except with respect to interest earned on the funds held in the Trust
Account that may be released to Apex to pay its tax obligations, if any, the cash in the Trust Account may be disbursed only for
the purposes set forth in the Apex Prospectus. For and in consideration of Apex entering into this Subscription Agreement, the
receipt and sufficiency of which are hereby acknowledged, the Investor hereby irrevocably waives any and all right, title and interest,
or any claim of any kind it has or may have in the future, in or to any monies held in the Trust Account, regardless of whether
such claim arises as a result of, in connection with or relating in any way to, this Subscription Agreement or any proposed or
actual business relationship between Apex or its affiliates, on the one hand, and the Investor or its representatives, on the other
hand, or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal
liability and irrevocably agrees not to seek recourse against the Trust Account as a result of, or arising out of, this Subscription
Agreement. Investor agrees and acknowledges that such irrevocable waiver is material to this Subscription Agreement and specifically
relied upon by Apex and its affiliates to induce Apex to enter in this Subscription Agreement, and each such party further intends
and understands such waiver to be valid, binding and enforceable against the Investor and its affiliates under applicable law.
To the extent Investor commences any action or proceeding based upon, in connection with, relating to or arising out of any matter
relating to Apex or its affiliates, which proceeding seeks, in whole or in part, monetary relief against Apex or its affiliates,
the Investor hereby acknowledges and agrees that the Investor’s sole remedy shall be against funds held outside of the Trust
Account and that such claim shall not permit the Investor (or any person claiming on any of their behalves or in lieu of any of
the Investor) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein
and in the event of any action or proceeding based upon, in connection with, relating to or arising out of any matter relating
to Apex or its affiliates, which proceeding seeks, in whole or in part, relief against the Trust Account (including any distributions
therefrom) in violation of this Subscription Agreement, Apex shall be entitled to recover from the Investor and its affiliates,
the associated legal fees and costs in connection with any such action, in the event Apex or its affiliates, as applicable, prevails
in such action or proceeding. Notwithstanding anything else in this Section 10 to the contrary, nothing herein shall be deemed
to limit the Investor's or its affiliates' right, title, interest or claim to the Trust Account by virtue of the Investor’s
record or beneficial ownership of Shares of Apex acquired by any means other than pursuant to this Subscription Agreement, including
but not limited to any redemption right with respect to any such securities of Apex.

 

11. Miscellaneous.

 

(a) Neither
this Subscription Agreement nor any rights that may accrue to the Investor hereunder (other than the Shares acquired hereunder,
if any) may be transferred or assigned, other than an assignment to any fund or account managed by the same investment manager
as the Investor or an affiliate thereof, subject to, if such transfer or assignment is prior to the Closing, such transferee or
assignee, as applicable, executing a joinder to this Subscription Agreement or a separate subscription agreement in substantially
the same form as this Subscription Agreement, including with respect to the Subscription Amount and other terms and conditions,
provided, that, in the case of any such transfer or assignment, the initial party to this Subscription Agreement shall remain
bound by its obligations under this Subscription Agreement in the event that the transferee or assignee, as applicable, does not
comply with its obligations to consummate the purchase of Shares contemplated hereby. Neither this Subscription Agreement nor any
rights that may accrue to Apex hereunder or any of Apex’s obligations may be transferred or assigned other than pursuant
to the Transactions.

 

(b) Apex
may request from the Investor such additional information as Apex may deem necessary to evaluate the eligibility of the Investor
to acquire the Shares and in connection with the inclusion of the Shares in the Registration Statement, and the Investor shall
provide such information as may reasonably be requested, to the extent readily available and to the extent consistent with its
internal policies and procedures. The Investor acknowledges that Apex may file a copy of this Subscription Agreement with the SEC
as an exhibit to a current or periodic report or a registration statement of Apex.

 

     12

     

    

 

(c) The
Investor acknowledges that Apex, the Placement Agents (as third party beneficiaries with right of enforcement) and others will
rely on the acknowledgments, understandings, agreements, representations and warranties of the Investor contained in this Subscription
Agreement. Prior to the Closing, the Investor agrees to promptly notify Apex, the Company and the Placement Agents if any of the
acknowledgments, understandings, agreements, representations and warranties of the Investor set forth herein are no longer accurate.
The Investor acknowledges and agrees that each purchase by the Investor of Shares from Apex will constitute a reaffirmation of
the acknowledgments, understandings, agreements, representations and warranties herein (as modified by any such notification) by
the Investor as of the time of such purchase.

 

(d) Apex,
the Placement Agents and the Investor are each entitled to rely upon this Subscription Agreement and each is irrevocably authorized
to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official
inquiry with respect to the matters covered hereby.

 

(e) All
of the representations and warranties contained in this Subscription Agreement shall survive the Closing. All of the covenants
and agreements made by each party hereto in this Subscription Agreement shall survive the Closing.

 

(f) This
Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 8 above)
except by an instrument in writing, signed by each of the parties hereto and, to the extent required by the Transaction Agreement,
the Company. No failure or delay of either party in exercising any right or remedy hereunder shall operate as a waiver thereof,
nor shall any single or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such
right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or
power. The rights and remedies of the parties and third party beneficiaries hereunder are cumulative and are not exclusive of any
rights or remedies that they would otherwise have hereunder.

 

(g) This
Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements,
understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof.
Except as set forth in Section 11(c) with respect to the persons referenced therein, this Subscription Agreement
shall not confer any rights or remedies upon any person other than the parties hereto, and their respective successor and assigns.

 

(h) Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto
and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations,
warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors,
administrators, successors, legal representatives and permitted assigns.

 

(i) If
any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or
unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in
any way be affected or impaired thereby and shall continue in full force and effect.

 

(j) This
Subscription Agreement may be executed in one or more counterparts and by different parties in separate counterparts, with the
same effect as if all parties hereto had signed the same document. Counterparts may be delivered via facsimile, electronic mail
(including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic
Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so
delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. All counterparts
so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

     13

     

    

 

(k) The
parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Subscription
Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting
a bond or undertaking and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement,
this being in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise.
The parties hereto acknowledge and agree that the Company and the Placement Agents shall be entitled to specifically enforce the
Investor’s obligations to fund the Subscription Amount and the provisions of the Subscription Agreement of which the Company
and the Placement Agent are each an express third party beneficiary, in each case, on the terms and subject to the conditions set
forth herein.

 

(l) THE
PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE court of chancery
of the state of delaware (or, to the extent such court does not have subject matter jurisdiction, the superior court of the state
of delaware, or the united states district court for the district of delaware) SOLELY IN RESPECT OF THE INTERPRETATION AND
ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT AND THE DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN
RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR
PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT
OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR
THAT THIS SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY
AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A delaware
STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND
OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT
OR PROCEEDING IN THE MANNER PROVIDED IN THIS SECTION 11(l) OF THIS SUBSCRIPTION AGREEMENT OR IN SUCH OTHER MANNER
AS MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.

 

(m) EACH
PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY
WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF
OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES
AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS
AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY; AND
(IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS
IN THIS SECTION 11(m). 

 

     14

     

    

 

12. Non-Reliance
and Exculpation. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation
or warranty made by any person, firm or corporation (including, without limitation, the Placement Agents, any of their respective
affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing),
other than the statements, representations and warranties of Apex expressly contained in Section 5 of this Subscription
Agreement, in making its investment or decision to invest in Apex. The Investor acknowledges and agrees that none of (i) any
other investor pursuant to this Subscription Agreement or any other subscription agreement related to the private placement of
the Shares (including the investor’s respective affiliates or any control persons, officers, directors, employees, partners,
agents or representatives of any of the foregoing), (ii) the Placement Agents, their respective affiliates or any control
persons, officers, directors, employees, partners, agents or representatives of any of the foregoing, (iii) any other party
to the Transaction Agreement (other than Apex), or (iv) any affiliates, or any control persons, officers, directors, employees,
partners, agents or representatives of any of Apex, the Company or any other party to the Transaction Agreement shall be liable
to the Investor, or to any other investor, pursuant to this Subscription Agreement or any other subscription agreement related
to the private placement of the Shares, the negotiation hereof or thereof or the subject matter hereof or thereof, or the transactions
contemplated hereby or thereby, for any action heretofore or hereafter taken or omitted to be taken by any of them in connection
with the purchase of the Shares, including, without limitation, with respect to any action heretofore or hereafter taken or omitted
to be taken by any of them in connection with the purchase of the Shares or with respect to any claim (whether in tort, contract
or otherwise) for breach of this Subscription Agreement or in respect of any written or oral representations made or alleged to
be made in connection herewith, as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions
with respect to any information or materials of any kind furnished by Apex, the Company, the Placement Agents or any Non-Party
Affiliate concerning Apex, the Company, the Placement Agents, any of their affiliates, this Subscription Agreement or the transactions
contemplated hereby. For purposes of this Subscription Agreement, “Non-Party Affiliates” means each former, current
or future officer, director, employee, partner, member, manager, direct or indirect equityholder or affiliate of Apex, the Company,
the Placement Agent or any of Apex’s, the Company’s or the Placement Agents’ respective affiliates or any family
member of the foregoing.

 

13. Press
Releases. Apex shall, by 9:00 a.m., New York City time, on the first business day immediately following the date of this Subscription
Agreement, issue one or more press releases or furnish or file with the SEC a Current Report on Form 8-K (collectively, the
“Disclosure Document”) disclosing, to the extent not previously publicly disclosed, the PIPE Investment, all
material terms of the Transaction and any other material, non-public information that Apex has provided to the Investor at any
time prior to the filing of the Disclosure Document. From and after the disclosure of the Disclosure Document, to the knowledge
of Apex, the Investors shall not be in possession of any material, non-public information received from Apex or any of its officers,
directors, agents or employees and the Investor shall no longer be subject to any confidentiality or similar obligations under
any current agreement, whether written or oral with Apex or any of its respective affiliates. All press releases or other public
communications relating to the transactions contemplated hereby between Apex and the Investor, and the method of the release for
publication thereof, shall be subject to the prior approval of (i) Apex, and (ii) to the extent such press release or
public communication references the Investor or its affiliates or investment advisers by name, the Investor; provided that
neither Apex nor the Investor shall be required to obtain consent pursuant to this Section 13 to the extent any proposed
release or statement is substantially equivalent to the information that has previously been made public without breach of the
obligation under this Section 13. The restriction in this Section 13 shall not apply to the extent the
public announcement is required by applicable securities law, any governmental authority or stock exchange rule; provided,
that in such an event, the applicable party shall use its commercially reasonable efforts to consult with the other party in advance
as to its form, content and timing.

 

14. Notices.
All notices and other communications among the parties shall be in writing and shall be deemed to have been duly given (i) when
delivered in person, (ii) when delivered after posting in the United States mail having been sent registered or certified
mail return receipt requested, postage prepaid, (iii) when delivered by FedEx or other nationally recognized overnight delivery
service, or (iv) when delivered by email (in each case in this clause (iv), solely if receipt is confirmed, but excluding
any automated reply, such as an out-of-office notification), addressed as follows:

 

If to the Investor, to the address
provided on the Investor’s signature page hereto.

 

If to Apex, to:

 

	 	Apex Technology Acquisition Corporation

    533 Airport Blvd., Ste. 400
	 	Burlingame, CA
	 	Attention:  	Brad Koenig
	 	Email:    	###########

 

     15

     

    

 

with copies to (which shall not constitute notice),
to:

 

	 	Latham & Watkins LLP
	 	140 Scott Dr.
	 	Menlo Park, CA 94025
	 	Attention:  	Josh Dubofsky
	 	 	
        Brian Paulson

        Michael Podolny

	 	 	 
	 	Email:    	#######
	 	 	#######
	 	 	#######
	 	 
	 	And
	 	 
	 	AvePoint, Inc.
	 	
        Riverfront Plaza, West Tower

        901 East Byrd Street, Suite 900

        Richmond, VA 23219

	 	Attention:  	Brian Brown
	 	Email:    	#######
	 	 
	 	And
	 	 
	 	Cooley LLP
	 	11951 Freedom Dr., 14th Floor
	 	Reston, VA 20190
	 	Attention:  	Michael Lincoln
	 	 	
        Brian Leaf

        John McKenna

	 	 	 
	 	Email:    	#######
	 	 	#######
	 	 	#######

 

or to such other address or addresses as
the parties may from time to time designate in writing. Copies delivered solely to outside counsel shall not constitute notice.

 

[SIGNATURE PAGES FOLLOW]

 

     16

     

    

 

IN WITNESS WHEREOF,
the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the
date set forth below.

 

	Name of Investor:	 	State/Country of Formation or Domicile:
	 	 	 
	By:	             	 	 
	Name:	 	 	 
	Title:	 	 	 
	 	 	 
	Name in which Shares are to be registered
    (if different):	 	Date: ________, 2020
	 	 	 
	Investor’s EIN:	 	 
	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	City, State, Zip:	 	City, State, Zip:
	 	 	 
	Attn:	 	 	Attn:	 
	 	 	 
	Telephone No.:	 	Telephone No.:
	Facsimile No.:	 	Facsimile No.:
	 	 	 
	Number of Shares subscribed for:	 	 
	 	 	 
	Aggregate Subscription Amount: $	 	Price Per Share: $[ ● ]

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by Apex in the Closing
Notice.

  

 

(Signature Page to Subscription Agreement)

 

     

     

    

 

IN WITNESS WHEREOF, Apex has
accepted this Subscription Agreement as of the date set forth below.

 

	 	Apex Technology Acquisition Corp.
	 	 
	 	By:	     
	 	 	Name:
	 	 	Title:
	 	 	 
	Date:     , 2020	 	 

 

  

 

(Signature Page to Subscription Agreement)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]